Neurobehavioral & Cognitive Disorders
PART (Primary age-related tauopathy)
Apr. 24, 2023
This is an image preview.
Start a Free Account
to view the full image.
-
Nearly 3,000 illustrations, including video clips of neurologic disorders.
-
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
-
Full spectrum of neurology in 1,200 comprehensive articles.
-
Listen to MedLink on the go with Audio versions of each article.
Hyperintensities in limbic encephalitis after treatment with PD-1 inhibitor
Axial T2 FLAIR sequence MRI showing bilateral mesiotemporal hyperintensities (arrows) in a patient with a history of type 1 diabetes mellitus limbic encephalitis with underlying active non-small cell lung cancer, treated with durvalumab (PD-1 inhibitor) monthly infusions, stopped when he developed limbic encephalitis. His workup yielded positive GAD65 (serum titer: 533 nmole/L, CSF titer: 11.6 nmole/L). Although the titers are relatively high, GAD65 is rarely considered to be associated with underlying malignancy, and the use of immune checkpoint inhibitor makes irAE of a higher concern. (Contributed by Dr. Lama Abdel Wahed.)